$1.31 Billion is the total value of BRIDGER MANAGEMENT, LLC's 39 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 133.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $65,973,000 | +52.3% | 422,254 | +11.6% | 5.03% | +45.3% |
| ROST | Buy | ROSS STORES INC | $55,238,000 | +75.0% | 449,783 | +33.0% | 4.21% | +66.9% |
| UBER | Buy | UBER TECHNOLOGIES INC | $51,944,000 | +78.0% | 1,018,500 | +27.3% | 3.96% | +69.8% |
| MRK | Buy | MERCK & CO. INC | $48,218,000 | +24.7% | 589,461 | +26.4% | 3.68% | +19.0% |
| INCY | Buy | INCYTE CORP | $35,196,000 | +14.4% | 404,650 | +18.0% | 2.68% | +9.1% |
| FTDR | Buy | FRONTDOOR INC | $23,850,000 | +172.4% | 475,000 | +111.1% | 1.82% | +159.9% |
| SQZ | New | SQZ BIOTECHNOLOGIES CO | $23,411,000 | – | 807,827 | +100.0% | 1.79% | – |
| LIVN | New | LIVANOVA PLC | $14,335,000 | – | 216,515 | +100.0% | 1.09% | – |
| ZBH | New | ZIMMER BIOMET HOLDINGS INC | $13,725,000 | – | 89,070 | +100.0% | 1.05% | – |
| FCNCA | New | FIRST CTZNS BANCSHARES INC Ncl a | $11,485,000 | – | 20,000 | +100.0% | 0.88% | – |
| AVANU | New | AVANTI ACQUISITION CORPunit 99/99/9999 | $10,840,000 | – | 1,000,000 | +100.0% | 0.83% | – |
| ACACU | New | ACIES ACQUISITION CORPunit 11/30/2027 | $9,648,000 | – | 900,000 | +100.0% | 0.74% | – |
| CHFWU | New | CONSONANCE HFW ACQUISITION Cunit 99/99/9999 | $7,329,000 | – | 700,000 | +100.0% | 0.56% | – |
| New | DERMTECH INC | $5,849,000 | – | 180,304 | +100.0% | 0.45% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.